Suppr超能文献

血管病变、APOE ε4 和阿尔茨海默病中的 Tau 病理学。

Vascular Lesions, APOE ε4, and Tau Pathology in Alzheimer Disease.

机构信息

From the Arizona College of Osteopathic Medicine, Midwestern University, Glendale, Arizona, USA.

Banner Alzheimer's Institute, Phoenix, Arizona, USA.

出版信息

J Neuropathol Exp Neurol. 2021 Feb 22;80(3):240-246. doi: 10.1093/jnen/nlaa160.

Abstract

We sought to determine the associations among cerebral amyloid angiopathy (CAA), white matter rarefaction (WMR), circle of Willis atherosclerosis (CWA), and total microinfarct number with Braak neurofibrillary stage in postmortem individuals with and without Alzheimer disease (AD). Data from 355 cases of autopsied individuals with Braak stage I-VI who had antemortem consensus diagnoses of cognitively unimpaired (n = 183), amnestic mild cognitive impairment (n = 31), and AD dementia (n = 141) were used. The association between Braak stage and vascular lesions were individually assessed using multivariable linear regression that adjusted for age at death, APOE ε4 carrier status, sex, education, and neuritic plaque density. CAA (p = 0.007) and WMR (p < 0.001) were associated with Braak stage, independent of amyloid load; microinfarct number and CWA showed no association. Analyses of the interactions between APOE ε4 carrier status and vascular lesions found that greater WMR and positive ε4 carrier status were associated with higher Braak stages. These results suggest that CAA and WMR are statistically linked to the severity of AD-related NFT pathology. The statistical link between WMR and NFT load may be strengthened by the presence of APOE ε4 carrier status. An additional finding was that Lewy body pathology was most prevalent in higher Braak stages.

摘要

我们旨在确定脑淀粉样血管病(CAA)、脑白质疏松(WMR)、Willis 环动脉粥样硬化(CWA)和总微梗死数量与阿尔茨海默病(AD)尸检个体的 Braak 神经纤维阶段之间的关联。使用了 355 例具有 Braak 阶段 I-VI 的尸检个体的数据,这些个体在生前具有认知未受损(n=183)、遗忘型轻度认知障碍(n=31)和 AD 痴呆(n=141)的共识诊断。使用多变量线性回归,在调整死亡年龄、APOE ε4 携带状态、性别、教育程度和神经原纤维缠结密度后,分别评估 Braak 阶段与血管病变之间的关联。CAA(p=0.007)和 WMR(p<0.001)与 Braak 阶段相关,与淀粉样蛋白负荷无关;微梗死数量和 CWA 没有关联。对 APOE ε4 携带状态与血管病变之间相互作用的分析发现,较大的 WMR 和阳性 ε4 携带状态与较高的 Braak 阶段相关。这些结果表明,CAA 和 WMR 与 AD 相关 NFT 病理的严重程度在统计学上存在关联。APOE ε4 携带状态的存在可能会增强 WMR 与 NFT 负荷之间的统计学联系。另一个发现是路易体病理学在较高的 Braak 阶段最为普遍。

相似文献

1
Vascular Lesions, APOE ε4, and Tau Pathology in Alzheimer Disease.
J Neuropathol Exp Neurol. 2021 Feb 22;80(3):240-246. doi: 10.1093/jnen/nlaa160.
2
Association of Apolipoprotein E ε4 With Transactive Response DNA-Binding Protein 43.
JAMA Neurol. 2018 Nov 1;75(11):1347-1354. doi: 10.1001/jamaneurol.2018.3139.
3
APOE, vascular pathology, and the AD brain.
Neurology. 2005 Jul 26;65(2):259-65. doi: 10.1212/01.wnl.0000168863.49053.4d.
5
Increased Alzheimer's disease neuropathology is associated with type 2 diabetes and ApoE ε.4 carrier status.
Curr Alzheimer Res. 2013 Jul;10(6):654-9. doi: 10.2174/15672050113109990006.
6
Lewy body pathology modifies risk factors for cerebral amyloid angiopathy when comorbid with Alzheimer's disease pathology.
Alzheimers Dement. 2024 Apr;20(4):2564-2574. doi: 10.1002/alz.13704. Epub 2024 Feb 14.
7
Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4.
Neuropathol Appl Neurobiol. 2003 Oct;29(5):503-10. doi: 10.1046/j.1365-2990.2003.00453.x.
9
Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease.
Acta Neuropathol. 2008 Apr;115(4):427-36. doi: 10.1007/s00401-008-0347-5. Epub 2008 Feb 14.

引用本文的文献

1
Distinct Characteristics of Suspected Non-Alzheimer Pathophysiology in Relation to Cognitive Status and Cerebrovascular Burden.
Clin Nucl Med. 2025 May 1;50(5):368-380. doi: 10.1097/RLU.0000000000005793. Epub 2025 Mar 3.
2
The influence of APOE on the pTau interactome in sporadic Alzheimer's disease.
Acta Neuropathol. 2024 May 21;147(1):91. doi: 10.1007/s00401-024-02744-8.
3
ApoER2-Dab1 disruption as the origin of pTau-associated neurodegeneration in sporadic Alzheimer's disease.
Acta Neuropathol Commun. 2023 Dec 13;11(1):197. doi: 10.1186/s40478-023-01693-9.
5
Emerging role of vascular burden in AT(N) classification in individuals with Alzheimer's and concomitant cerebrovascular burdens.
J Neurol Neurosurg Psychiatry. 2023 Dec 14;95(1):44-51. doi: 10.1136/jnnp-2023-331603.
10
Discovering Gene Signature Shared by Prostate Cancer and Neurodegenerative Diseases Based on the Bioinformatics Approach.
Comput Math Methods Med. 2022 Jun 28;2022:8430485. doi: 10.1155/2022/8430485. eCollection 2022.

本文引用的文献

1
Alzheimer's Disease Neuropathological Comorbidities are Common in the Younger-Old.
J Alzheimers Dis. 2021;79(1):389-400. doi: 10.3233/JAD-201213.
2
Molecular Insight into the Therapeutic Promise of Targeting for Alzheimer's Disease.
Oxid Med Cell Longev. 2020 May 15;2020:5086250. doi: 10.1155/2020/5086250. eCollection 2020.
4
2020 Alzheimer's disease facts and figures.
Alzheimers Dement. 2020 Mar 10. doi: 10.1002/alz.12068.
6
Braak Stage, Cerebral Amyloid Angiopathy, and Cognitive Decline in Early Alzheimer's Disease.
J Alzheimers Dis. 2020;74(1):189-197. doi: 10.3233/JAD-191151.
7
Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies.
Nat Rev Neurol. 2019 Sep;15(9):501-518. doi: 10.1038/s41582-019-0228-7. Epub 2019 Jul 31.
8
Vascular dysfunction-The disregarded partner of Alzheimer's disease.
Alzheimers Dement. 2019 Jan;15(1):158-167. doi: 10.1016/j.jalz.2018.07.222.
9
Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease.
Pathology. 2019 Feb;51(2):165-176. doi: 10.1016/j.pathol.2018.11.002. Epub 2018 Dec 28.
10
Vascular Risk and β-Amyloid Are Synergistically Associated with Cortical Tau.
Ann Neurol. 2019 Feb;85(2):272-279. doi: 10.1002/ana.25399. Epub 2019 Jan 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验